John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 20,000 shares at $40.15 ($805K) on 2015-03-09, disclosed to the SEC on 2015-03-10.
Scheduled sale ($805k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.15 | 17,499 | $703K | 87.3% |
| 2 | $40.93 | 2,501 | $102K | 12.7% |
| Total | $40.25 avg | 20,000 | $805K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |